In an effort to support the response to the COVID-19 pandemic, Mubadala Healthcare has introduced various initiatives across its assets in cooperation with the Ministry of Health and Prevention, Department of Health in Abu Dhabi and the Dubai Health Authority. Hasan Jasem Al Nowais, Senior Vice President at Mubadala Healthcare, sheds light on Mubadala Healthcare’s commitment to fight against the spread of COVID-19.

To date, over 220,000 COVID-19 tests have been administered throughout the UAE with Mubadala Healthcare’s National Reference Laboratory (NRL) working around the clock and processing over 25,000 of those tests. Each day 1,000 tests are processed, and in the coming weeks NRL will expand its testing capabilities to 5,000 tests a day.

Mubadala Healthcare facilities also launched critical medication delivery directly to patients’ homes across the UAE. There have been over 3,750 critical prescriptions delivered to date. Cleveland Clinic Abu Dhabi accounts for 50% of those prescriptions. Additionally, a COVID-19 drive-through testing site has been launched at Healthpoint, which is screening on average 270 patients daily with a total of 1,742 patients serviced to date.

Patient calls have increased by 2,000% at the Abu Dhabi Telemedicine Centre since March due to the COVID-19 pandemic. The center has expanded telecare operations and increased staff members to handle the growing volume of calls from patients, regardless of their insurance coverage. This service limits patients’ potential exposure to viruses and reduces pressure on hospitals across Abu Dhabi.

Mubadala Healthcare is also providing flexible payment plans across its network for patients that are not insured.